Purpose of review With increasing survival of patients with stage D heart failure, the demand
for heart transplantation has increased. The supply of donor hearts remains relatively …

Heart transplantation remains the definitive management for end-stage heart failure
refractory to medical therapy. While heart transplantation cases are increasing annually …

Objectives Heart donation after circulatory death was recently reintroduced in the United
States with hopes of increasing donor heart availability. We examined its national use and …

BACKGROUND: Organ availability limits use of heart transplantation for treatment for end-
stage heart disease. Hearts are currently obtained from donors declared brain dead (heart …

In the previous 2 decades, there have been many advances in the treatment of coronary and
valvular heart disease. However, these treatments remain imperfect, and more patients are …

Historically, heart transplantation (HT) has relied on the use of traditional cold storage for
donor heart preservation. This organ preservation modality has several limitations, including …

Introduction Heart transplantation is the treatment of choice for end-stage heart failure. There
is a mismatch between the number of donor hearts available and the number of patients …

Heart transplantation has become the accepted treatment for advanced heart failure, with
over 4000–5000 performed in the world annually. Although the number of yearly transplants …

Heart transplantation remains the gold standard therapy for patients with advanced heart
failure; however, the utilization of heart transplantation is constrained by the limited supply of …

The adoption of cardiac transplantation following circulatory death has increased overall
cardiac transplantation in those transplant centers who have incorporated these donors …